NO904112L - Antimikrobielle sammensetninger. - Google Patents

Antimikrobielle sammensetninger.

Info

Publication number
NO904112L
NO904112L NO90904112A NO904112A NO904112L NO 904112 L NO904112 L NO 904112L NO 90904112 A NO90904112 A NO 90904112A NO 904112 A NO904112 A NO 904112A NO 904112 L NO904112 L NO 904112L
Authority
NO
Norway
Prior art keywords
antimicrobial compositions
formula
compounds
antimicrobial
alk3
Prior art date
Application number
NO90904112A
Other languages
English (en)
Other versions
NO179472B (no
NO179472C (no
NO904112D0 (no
Inventor
Gyoergy Lajos Kis
Original Assignee
Dispersa Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dispersa Ag filed Critical Dispersa Ag
Publication of NO904112D0 publication Critical patent/NO904112D0/no
Publication of NO904112L publication Critical patent/NO904112L/no
Publication of NO179472B publication Critical patent/NO179472B/no
Publication of NO179472C publication Critical patent/NO179472C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
    • A61L12/143—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Eyeglasses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO904112A 1989-09-21 1990-09-20 Opplösning omfattende benzoxoniumklorid for behandling av kontaktlinser, og anvendelse derav til konservering av kontaktlinser og legemidler for öynene NO179472C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH344689 1989-09-21

Publications (4)

Publication Number Publication Date
NO904112D0 NO904112D0 (no) 1990-09-20
NO904112L true NO904112L (no) 1991-03-22
NO179472B NO179472B (no) 1996-07-08
NO179472C NO179472C (no) 1996-10-16

Family

ID=4256126

Family Applications (1)

Application Number Title Priority Date Filing Date
NO904112A NO179472C (no) 1989-09-21 1990-09-20 Opplösning omfattende benzoxoniumklorid for behandling av kontaktlinser, og anvendelse derav til konservering av kontaktlinser og legemidler for öynene

Country Status (18)

Country Link
EP (1) EP0420798B1 (no)
JP (1) JP2960507B2 (no)
AT (1) ATE103182T1 (no)
AU (1) AU640687B2 (no)
CA (1) CA2025728C (no)
DD (1) DD299267A5 (no)
DE (1) DE59005084D1 (no)
DK (1) DK0420798T3 (no)
ES (1) ES2053161T3 (no)
FI (1) FI101849B (no)
HU (2) HUT59001A (no)
IE (1) IE71639B1 (no)
IL (1) IL95720A (no)
NO (1) NO179472C (no)
NZ (1) NZ235377A (no)
PH (1) PH29982A (no)
PT (1) PT95355B (no)
ZA (1) ZA907536B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037647A (en) * 1988-09-15 1991-08-06 Alcon Laboratories, Inc. Aqueous antimicrobial opthalmic solutions comprised of quaternary ammonium compound, citric acid, citrate and sodium chloride
AU6859394A (en) * 1993-05-25 1994-12-20 Auckland Uniservices Limited Nitrobenzyl mustard quaternary salts and their use as hypoxia-selective cytotoxic agents
JP4849288B2 (ja) * 2000-09-29 2012-01-11 ライオン株式会社 点眼剤及び涙液膜の安定化剤
JP2010031052A (ja) * 2002-04-08 2010-02-12 Lion Corp 眼科用組成物、及び眼科製剤用防腐組成物
US20050214382A1 (en) * 2004-03-29 2005-09-29 Erning Xia Zinc preservative composition and method of use
DE202005005094U1 (de) * 2005-03-31 2005-07-28 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Ophthalmische Zusammensetzung
EP2364140A1 (en) * 2008-11-28 2011-09-14 Advance Holdings Limited Pharmaceutical formulation comprising diclofenac and a hydroxy fatty acid polyoxyalkylene ester
JP2012006962A (ja) * 2011-08-22 2012-01-12 Lion Corp 眼科用組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR204836A1 (es) * 1973-09-24 1976-03-05 Allergan Pharma Composicion para esterilizar lentes de contacto blandos
DE3612537C1 (de) * 1986-04-14 1987-07-16 Dispersa Ag Arzneimittel zur Behandlung von Entzuendungen im Auge
KR950013754B1 (ko) * 1987-09-11 1995-11-15 신텍스(미합중국)인코포레이티드 안과용 비스테로이드계 소염제제

Also Published As

Publication number Publication date
IL95720A0 (en) 1991-06-30
JPH03130219A (ja) 1991-06-04
ATE103182T1 (de) 1994-04-15
ES2053161T3 (es) 1994-07-16
HU210525A9 (en) 1995-04-28
DK0420798T3 (da) 1994-04-11
IL95720A (en) 1996-07-23
AU6302490A (en) 1991-03-28
HUT59001A (en) 1992-04-28
NZ235377A (en) 1992-08-26
FI101849B1 (fi) 1998-09-15
NO179472B (no) 1996-07-08
FI101849B (fi) 1998-09-15
PH29982A (en) 1996-10-29
JP2960507B2 (ja) 1999-10-06
EP0420798A1 (de) 1991-04-03
CA2025728A1 (en) 1991-03-22
IE71639B1 (en) 1997-02-26
FI904616A0 (fi) 1990-09-19
DE59005084D1 (de) 1994-04-28
NO179472C (no) 1996-10-16
PT95355B (pt) 1997-06-30
PT95355A (pt) 1991-05-22
HU905995D0 (en) 1991-03-28
EP0420798B1 (de) 1994-03-23
CA2025728C (en) 2002-02-26
AU640687B2 (en) 1993-09-02
IE903406A1 (en) 1991-04-10
NO904112D0 (no) 1990-09-20
ZA907536B (en) 1991-05-29
DD299267A5 (de) 1992-04-09

Similar Documents

Publication Publication Date Title
PT1235826E (pt) Acrilamidas de quinuclidina
ES2191048T3 (es) Derivados de oxazolidinona y compuestos farmaceuticos que los contienen.
ATE211384T1 (de) Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera
FI903153A0 (fi) 11b-aryl-4-estrener, foerfarande foer deras framstaellning samt deras anvaendning som laekemedel.
CA2309172A1 (en) Aminobiguanides to disinfect contact lenses and preserve pharmaceutical compositions
ES2160649T3 (es) Nuevos compuestos lactamicos y procedimientos para su preparacion.
DE59008356D1 (de) Heterocyclische Verbindungen.
ATE103182T1 (de) Antimikrobielle zusammensetzungen.
DE69218816D1 (de) N-acetyl-cysteine Derivate enthaltende pharmazeutische Zusammensetzung zur Behandlung von Katarakt
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
GR3022604T3 (en) Inhibitors of hiv protease useful for the treatment of aids.
ES2092645T3 (es) Metanoantracenos como antagonistas de dopamina.
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
DE69117974D1 (de) Pharmazeutische zusammensetzungen zur behandlung von b-zell-entartungen